Zscaler: Cheap Compared To Closest Peers For No Good Reason

Zscaler shares are down 39% versus the benchmark’s 19% gain, reflecting significant volatility and recent underperformance. The article argues there’s no structural deterioration in fundamentals and that ZS is now trading at ~35x forward P/E, viewed as fairly valued given strengthened business metrics. Overall, the takeaway is cautious/uncertain rather than a clear fundamental re-rating.

Analysis

The de-rating has likely moved ZS from a momentum/multiple-expansion story to a fundamentals-and-execution story. That matters because the stock no longer needs perfect growth to work, but it also loses the reflexive bid that comes from being owned as a high-beta software compounder. In the near term, that usually means lower downside but also a tighter range unless management can reaccelerate billings or prove stronger free-cash-flow leverage.

Competitive pressure is the real second-order issue. ZS sits in a crowded security stack where PANW can bundle more broadly, CRWD can cross-sell into adjacent workloads, and FTNT can compete on price/performance in network security. If ZS is stable, the market should read that as evidence enterprise security budgets are holding up; if not, the weakness will likely show up first in deal size, win rates, and renewal terms rather than in headline revenue.

Contrarian view: the market may be underestimating how quickly “fair value” can re-rate lower if growth remains merely steady rather than re-accelerating. At ~35x forward earnings, the stock is not expensive in absolute terms, but it is still a duration asset; if rates back up or software multiples compress, that multiple can still drift toward the low-30s without any fundamental break. What would falsify the bull case is any sequential slowdown in billings/cRPO, margin slippage from pricing pressure, or guidance that confirms stabilization is just optically driven by tougher comps rather than demand inflection.

Key Decisions for Investors

• Maintain a small/monitoring long in ZS only for a 3-6 month horizon; upside requires proof of re-acceleration, not just valuation support. Risk/reward is roughly 1.5:1 if the multiple expands into the low-40s, but downside reopens quickly on any guide miss.
• Prefer a relative-value long ZS / short FTNT pair into the next earnings cycle. Thesis: ZS has more room for multiple repair if execution stabilizes, while FTNT’s lower-growth profile is more vulnerable if security spending softens.
• Avoid chasing an outright long at current levels; instead, set a trigger to add only if next-quarter billings/cRPO and operating margin both improve sequentially. This keeps you out of the 'value trap' zone where the stock appears cheap but never re-accelerates.
• If already long higher-duration software, use ZS as a hedge candidate rather than adding beta elsewhere; a renewed software multiple reset would hurt names with similar duration but weaker FCF conversion first.
• Watch for a break below the post-selloff base or another guidance reset; that would invalidate the 'fairly valued' argument and likely push the stock toward a lower-teens FCF multiple rather than stabilize here.